G
$127.8–237.3K / year · South San Francisco, California, US
Genentech discovers and develops medicines for serious and life-threatening diseases through biomedical research and biotechnology.
Genentech discovers and develops medicines for people with serious and life-threatening diseases. Its work spans biotechnology, biomedical research, drug discovery and development, personalized medicine, artificial intelligence for molecule discovery and pharmaceutical manufacturing.
Founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer, Genentech is a member of the Roche Group. Its discoveries include what it describes as the first personalized medicine for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech says it has committed $50 billion to manufacturing and research and development in the United States. Its work also includes efforts to reduce barriers to clinical-trial participation and promote inclusive research.